Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

318
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
318
Symbiosis00:58

Symbiosis

28.2K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
28.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

334
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
334
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative bioavailability of three benznidazole formulations in healthy individuals: a randomised study.

Memorias do Instituto Oswaldo Cruz·2026
Same author

Towards elimination of Chagas disease.

Bulletin of the World Health Organization·2026
Same author

From invisibility to political power: Policy lessons from a decade of Brazil's Social Forum for Infectious and Neglected Diseases.

PLoS neglected tropical diseases·2026
Same author

Prevalence and factors associated with non-vaccination: a vaccination coverage survey among children born in Ceará, Brazil, 2017-2018.

Revista da Sociedade Brasileira de Medicina Tropical·2026
Same author

Graduate studies in Collective Health in Brazil: trajectories, evaluation, and challenges.

Cadernos de saude publica·2026
Same author

Paracoccidioidomycosis in Brazil: 25-Year Nationwide Trends in Mortality, Hospitalisations and In-Hospital Deaths of a Neglected Systemic Mycosis.

Tropical medicine & international health : TM & IH·2026

Related Experiment Video

Updated: Jul 8, 2025

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.3K

Chagas disease.

Andréa Silvestre de Sousa1, Debbie Vermeij2, Alberto Novaes Ramos3

  • 1Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; Department of Internal Medicine, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Lancet (London, England)
|December 10, 2023
PubMed
Summary

Chagas disease remains a global health issue due to high burden and emerging transmission routes. New strategies are vital for diagnosis, treatment, and control in a globalized world.

More Related Videos

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

1.5K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.2K

Related Experiment Videos

Last Updated: Jul 8, 2025

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.3K
Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

1.5K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.2K

Area of Science:

  • Neglected tropical diseases
  • Global health security
  • Epidemiology

Background:

  • Chagas disease presents a significant global public health challenge, characterized by substantial morbidity and mortality.
  • Despite treatment availability and transmission control efforts, epidemiological shifts like urbanization and globalization, alongside new transmission routes (oral, vertical), reclassify it as an emerging disease.
  • Significant obstacles in diagnosis, treatment, and care lead to underreported cases, hindering effective public policy development.

Purpose of the Study:

  • To highlight the evolving nature of Chagas disease as an emerging global health threat.
  • To underscore the limitations of current diagnostic and therapeutic tools.
  • To advocate for integrated surveillance and policy interventions addressing social determinants.

Main Methods:

  • Review of current epidemiological trends and challenges in Chagas disease management.
  • Analysis of barriers to diagnosis, treatment, and healthcare access.
  • Emphasis on the One Health approach and social determinants of health.

Main Results:

  • Chagas disease is increasingly recognized as an emerging disease due to global epidemiological changes and new transmission pathways.
  • Existing diagnostic and treatment options present limitations, restricting healthcare access.
  • Integrated surveillance, community participation, and addressing social determinants are crucial for effective control.

Conclusions:

  • Chagas disease requires updated public health strategies due to its emerging nature and persistent challenges.
  • Validation of novel diagnostic tools and treatments is essential to improve patient access to care.
  • A One Health framework incorporating community engagement and social determinant mitigation is critical for global Chagas disease control.